TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Turnover |
381,244
|
175,127 | |
| Financial expenses |
2,674
|
982 | |
| Earnings before taxes |
33,463
|
10,206 | |
| EBITDA |
41,886
|
28,076 | |
| Total assets |
221,337
|
194,371 | |
| Current assets |
114,863
|
95,743 | |
| Current liabilities |
91,886
|
92,804 | |
| Equity capital |
115,025
|
89,249 | |
| - share capital |
1,217
|
1,279 | |
| Employees (average) |
18
|
13
|
10 |
Financial ratios
| Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Solvency |
52.0%
|
45.9% | |
| Turnover per employee |
29,326
|
17,513 | |
| Profit as a percentage of turnover |
8.8%
|
5.8% | |
| Return on assets (ROA) |
16.3%
|
5.8% | |
| Current ratio |
125.0%
|
103.2% | |
| Return on equity (ROE) |
29.1%
|
11.4% | |
| Change turnover |
214,567
|
104,712 | |
| Change turnover % |
-37%
|
129%
|
149% |
| Chg. No. of employees |
5
|
3
|
2 |
| Chg. No. of employees % |
38%
|
30%
|
25% |
Total value of public sale
| Fiscal year | 2023/03 (consolidated) | 2022/03 (consolidated) | 2021/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.